AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Megmastate-MF Injection

Prescription Icon
Prescription Required

Marketer

Ridhima Biocare

Salt Composition

Tranexamic Acid (500mg)

Overview Megmastate-MF Injection

Hemostatin-MF Injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss associated with procedures such as tooth extraction, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. Hemostatin-MF Injection acts as an antifibrinolytic agent, inhibiting clot dissolution and thus promoting hemostasis. Administration should only be performed by a qualified medical practitioner. Contraindicated in individuals with hypersensitivity to this medication. Frequently reported adverse effects encompass injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Prior cardiac surgery or existing renal impairment necessitates physician consultation. The injection is deemed safe for use during pregnancy and lactation, as well as in patients with hepatic dysfunction.

Uses of Megmastate-MF Injection

Managing Hemorrhage

Major Benefits of Megmastate-MF Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Megmastate-MF Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Megmastate-MF Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Megmastate-MF Injection works:

Hemostatic agent Megmastate-MF Injection inhibits fibrinolysis, thereby stabilizing blood clots and managing excessive menstrual or post-surgical hemorrhage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Megmastate-MF Injection and alcohol may result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Megmastate-MF Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Megmastate-MF Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Megmastate-MF Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should receive Megmastate-MF Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Megmastate-MF Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary. Physician consultation is recommended.

What if you forget to take Megmastate-MF Injection :

Omit a Megmastate-MF Injection dose? Seek your physician's advice.

Facts to Know About Megmastate-MF Injection

LabelValue
Chemical Category Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Megmastate-MF Injection

Megmastate-MF Injection must be administered intravenously, via slow injection only. Intramuscular injection is contraindicated to avoid adverse reactions.
All medications carry potential side effects, though these are less likely if used as prescribed. Generally, the benefits outweigh the risks. However, Megmastate-MF Injection may rarely cause serious, potentially dangerous side effects, including anaphylaxis (rash, breathing difficulties, facial/oral/eyelid swelling), blood clots, or eye problems. Always consult your doctor before starting this medication and adhere strictly to their instructions.
Megmastate-MF Injection helps stop bleeding by promoting blood clotting. Rarely, it may increase the risk of deep vein thrombosis (DVT), a blood clot in the leg. Research suggests other factors may contribute to this risk, which appears higher in women using Megmastate-MF Injection. Consult your doctor before use and follow all instructions carefully.
Long-term Megmastate-MF Injection treatment may affect your color vision. Regular eye exams are recommended, and any vision changes should be reported to your doctor immediately. They may discontinue the medication and prescribe an alternative if necessary.
Megmastate-MF Injection can promote blood clotting, potentially leading to a pulmonary embolism (blood clot in the lungs), which is sometimes fatal. While uncommon, this risk is heightened by overdose, prolonged immobility, or predisposing conditions. Other factors may also contribute to this increased risk.
Take Megmastate-MF Injection with or without food, followed by a glass of water. Swallow the medicine whole; do not crush or chew it.
Dosage and treatment length for this medication vary depending on the condition. For heavy menstrual bleeding, it's typically prescribed for five days. For other conditions, the duration may be shorter or longer, as determined by your doctor.
Megmastate-MF Injection does not impair fertility. Prescribed for heavy menstrual bleeding, it shows no evidence of interfering with ovulation. Consequently, it's not a contraceptive and won't affect your pregnancy chances.
Yes, Megmastate-MF Injection can stop nosebleeds by promoting blood clotting. For persistent nosebleeds, it may be used for up to a week.
Megmastate-MF Injection
61
MRP 71
14% off